{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,5]],"date-time":"2026-10-05T05:53:36Z","timestamp":1791179616602,"version":"4.1.0"},"reference-count":19,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2026,10,5]],"date-time":"2026-10-05T00:00:00Z","timestamp":1791158400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Med."],"abstract":"<jats:sec>\n                    <jats:title>Background<\/jats:title>\n                    <jats:p>Adnexal masses discovered after hysterectomy are common, but the proportion that is malignant is low, and existing risk-stratification systems such as O-RADS were not developed or validated in this population. We aimed to develop and temporally validate a nomogram estimating the probability of malignancy among patients who have already been selected for surgical management of a post-hysterectomy adnexal mass.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>\n                      We retrospectively studied consecutive patients who underwent re-operation for an adnexal mass after prior benign hysterectomy at Beijing Obstetrics and Gynecology Hospital between January 2010 and October 2025. Patients operated from January 2010 to September 2023 formed the development cohort (\n                      <jats:italic>n<\/jats:italic>\n                      \u2009=\u2009233; 50 malignant, 183 benign); those operated from October 2023 to October 2025 formed the temporal validation cohort (\n                      <jats:italic>n<\/jats:italic>\n                      \u2009=\u200948; 20 malignant, 28 benign). Fourteen candidate predictors were screened by LASSO regression with 10-fold cross-validation. Final coefficients were obtained from unpenalised logistic regression on the selected predictors; the intercept of the seven-variable model was recalibrated on the development cohort because the originally reported intercept was inconsistent with the scaling of the continuous predictors. Performance was assessed by discrimination, calibration (intercept, slope, Brier score) and decision-curve analysis, with 1,000 bootstrap resamples for optimism correction.\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>\n                      The seven-variable nomogram comprises age (per 10 years), BMI (per 10\u2005kg\/m\n                      <jats:sup>2<\/jats:sup>\n                      ), tumour size (ordinal), cystic components, enriched blood flow\/enhancement, elevated CA125 (\u226570 U\/mL) and cyst duration (per 5 years). In the development cohort the AUC was 0.959 (95% CI 0.922\u20130.990) for the seven-variable model and 0.937 (0.885\u20130.979) for a simplified three-variable model (cystic components, enhancement, elevated CA125); the difference favoured the full model (\n                      <jats:italic>\u0394<\/jats:italic>\n                      AUC \u22120.023, 95% CI \u22120.045 to \u22120.005; DeLong\n                      <jats:italic>p<\/jats:italic>\n                      \u2009=\u20090.021). In the temporal validation cohort the AUC was 0.905 (0.791\u20130.985) and 0.929 (0.846\u20130.986), respectively (\n                      <jats:italic>\u0394<\/jats:italic>\n                      AUC +0.022, 95% CI \u22120.040 to 0.097;\n                      <jats:italic>p<\/jats:italic>\n                      \u2009=\u20090.517). Calibration was adequate in development (intercept 0.00, slope 1.02) and showed no statistically significant miscalibration in validation (intercept 0.29, 95% CI \u22120.71 to 1.28; slope 0.71, 95% CI 0.34 to 1.08). At the pre-specified 0.5 threshold the full model missed 8 of 50 malignancies in development and 6 of 20 in validation.\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusion<\/jats:title>\n                    <jats:p>We present a parsimonious nomogram that estimates malignancy risk in post-hysterectomy adnexal masses among patients already selected for surgery, with internal and temporal validation. Because all participants underwent surgery, the model cannot be used to justify non-operative management; independent external and prospective validation in unselected cohorts is required before any clinical implementation.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.3389\/fmed.2026.1915489","type":"journal-article","created":{"date-parts":[[2026,10,5]],"date-time":"2026-10-05T05:32:50Z","timestamp":1791178370000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":0,"title":["Development and temporal validation of a nomogram for estimating the risk of malignancy in surgically managed adnexal masses after hysterectomy"],"prefix":"10.3389","volume":"13","author":[{"given":"Le","family":"Xin","sequence":"first","affiliation":[{"name":"Department of Gynecological Minimal Invasive Center, Beijing Obstetrics and Gynecology Hospital, Capital Medical University, Beijing Maternal and Child Health Care Hospital","place":["Beijing, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anrui","family":"Yang","sequence":"additional","affiliation":[{"name":"Department of Gynecological Minimal Invasive Center, Beijing Obstetrics and Gynecology Hospital, Capital Medical University, Beijing Maternal and Child Health Care Hospital","place":["Beijing, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ming","family":"Wang","sequence":"additional","affiliation":[{"name":"Department of Gynecologic Oncology, Beijing Obstetrics and Gynecology Hospital, Laboratory for Clinical Medicine, Capital Medical University, Beijing Maternal and Child Health Care Hospital","place":["Beijing, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ying","family":"Zhang","sequence":"additional","affiliation":[{"name":"Department of Gynecological Minimal Invasive Center, Beijing Obstetrics and Gynecology Hospital, Capital Medical University, Beijing Maternal and Child Health Care Hospital","place":["Beijing, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2026,10,5]]},"reference":[{"key":"B1","first-page":"109","article-title":"Does hysterectomy without salpingo-oophorectomy influence the reoperation rate for adnexal pathology? A retrospective study","volume":"27","author":"Holub","year":"2000","journal-title":"Clin Exp Obstet Gynecol"},{"key":"B2","doi-asserted-by":"publisher","first-page":"67","DOI":"10.1016\/S0301-2115(97)02702-4","article-title":"Is it necessary to perform a prophylactic oophorectomy during hysterectomy?","volume":"73","author":"Zalel","year":"1997","journal-title":"Eur J Obstet Gynecol Reprod Biol"},{"key":"B3","doi-asserted-by":"publisher","first-page":"123","DOI":"10.1016\/j.ejogrb.2016.02.043","article-title":"Adnexal masses requiring reoperation in women with previous hysterectomy with or without adnexectomy","volume":"200","author":"Shiber","year":"2016","journal-title":"Eur J Obstet Gynecol Reprod Biol"},{"key":"B4","doi-asserted-by":"publisher","first-page":"168","DOI":"10.1148\/radiol.2019191150","article-title":"O-RADS US risk stratification and management system: a consensus guideline from the ACR ovarian-adnexal reporting and data system committee","volume":"294","author":"Andreotti","year":"2020","journal-title":"Radiology"},{"key":"B5","doi-asserted-by":"publisher","first-page":"3151","DOI":"10.3390\/cancers14133151","article-title":"Ovarian adnexal reporting data system (O-RADS) for classifying adnexal masses: a systematic review and meta-analysis","volume":"14","author":"Vara","year":"2022","journal-title":"Cancers (Basel"},{"key":"B6","doi-asserted-by":"publisher","first-page":"8794","DOI":"10.1200\/JCO.2005.01.7632","article-title":"Logistic regression model to distinguish between the benign and malignant adnexal mass before surgery: a multicenter study by the international ovarian tumor analysis group","volume":"23","author":"Timmerman","year":"2005","journal-title":"J Clin Oncol"},{"key":"B7","doi-asserted-by":"publisher","first-page":"g5920","DOI":"10.1136\/bmj.g5920","article-title":"Evaluating the risk of ovarian cancer before surgery using the ADNEX model to differentiate between benign, borderline, early and advanced stage invasive, and secondary metastatic tumours: prospective multicentre diagnostic study","volume":"349","author":"Van Calster","year":"2014","journal-title":"Br Med J"},{"key":"B8","doi-asserted-by":"publisher","first-page":"668","DOI":"10.1002\/uog.24777","article-title":"Performance of IOTA simple rules, simple rules risk assessment, ADNEX model and O-RADS in differentiating between benign and malignant adnexal lesions in north American women","volume":"59","author":"Hiett","year":"2022","journal-title":"Ultrasound Obstet Gynecol"},{"key":"B9","doi-asserted-by":"publisher","first-page":"114","DOI":"10.1148\/radiol.211868","article-title":"External validation of O-RADS US risk stratification and management system","volume":"304","author":"Hack","year":"2022","journal-title":"Radiology"},{"key":"B10","doi-asserted-by":"publisher","first-page":"g7594","DOI":"10.1136\/bmj.g7594","article-title":"Transparent reporting of a multivariable prediction model for individual prognosis or diagnosis (TRIPOD): the TRIPOD statement","volume":"350","author":"Collins","year":"2015","journal-title":"Br Med J"},{"key":"B11","doi-asserted-by":"publisher","first-page":"165","DOI":"10.4274\/jtgga.galenos.2018.2018.0051","article-title":"Adnexal lesions after hysterectomy: a retrospective observational study","volume":"20","author":"\u00d6ks\u00fczo\u011flu","year":"2019","journal-title":"J Turk Ger Gynecol Assoc"},{"key":"B12","doi-asserted-by":"publisher","first-page":"e19712","DOI":"10.1097\/MD.0000000000019712","article-title":"Malignant risk of pelvic mass after hysterectomy for adenomyosis or endometriosis","volume":"99","author":"Chao","year":"2020","journal-title":"Medicine (Baltimore"},{"key":"B13","doi-asserted-by":"publisher","first-page":"122","DOI":"10.1002\/ijgo.14110","article-title":"Appropriateness of hysterectomies at the time of surgical removal of presumed benign adnexal masses","volume":"159","author":"Barake","year":"2022","journal-title":"Int J Gynaecol Obstet"},{"key":"B14","doi-asserted-by":"publisher","first-page":"111122","DOI":"10.1016\/j.ejrad.2023.111122","article-title":"Improving risk stratification of indeterminate adnexal masses on MRI: what imaging features help predict malignancy in O-RADS MRI 4 lesions?","volume":"168","author":"Wong","year":"2023","journal-title":"Eur J Radiol"},{"key":"B15","doi-asserted-by":"publisher","first-page":"57","DOI":"10.1186\/s13048-023-01133-1","article-title":"Nomogram based on the O-RADS for predicting the malignancy risk of adnexal masses with complex ultrasound morphology","volume":"16","author":"Gong","year":"2023","journal-title":"J Ovarian Res"},{"key":"B16","doi-asserted-by":"publisher","first-page":"998","DOI":"10.1111\/jog.15540","article-title":"Diagnostic performance of CA125, HE4, ROMA, and CPH-I in identifying primary ovarian cancer","volume":"49","author":"Luo","year":"2023","journal-title":"J Obstet Gynaecol Res"},{"key":"B17","doi-asserted-by":"publisher","first-page":"188503","DOI":"10.1016\/j.bbcan.2021.188503","article-title":"Roles of CA125 in diagnosis, prediction, and oncogenesis of ovarian cancer","volume":"1875","author":"Zhang","year":"2021","journal-title":"Biochim Biophys Acta Rev Cancer"},{"key":"B18","doi-asserted-by":"publisher","first-page":"64","DOI":"10.1111\/1471-0528.14793","article-title":"Impact of endometriosis on risk of further gynaecological surgery and cancer: a national cohort study","volume":"125","author":"Saraswat","year":"2018","journal-title":"BJOG"},{"key":"B19","doi-asserted-by":"publisher","first-page":"213","DOI":"10.1007\/s11596-014-1261-9","article-title":"Risk factors for recurrence of ovarian endometriomas after surgical excision","volume":"34","author":"Yuan","year":"2014","journal-title":"J Huazhong Univ Sci Technolog Med Sci"}],"container-title":["Frontiers in Medicine"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fmed.2026.1915489\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,10,5]],"date-time":"2026-10-05T05:32:51Z","timestamp":1791178371000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fmed.2026.1915489\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,10,5]]},"references-count":19,"alternative-id":["10.3389\/fmed.2026.1915489"],"URL":"https:\/\/doi.org\/10.3389\/fmed.2026.1915489","relation":{},"ISSN":["2296-858X"],"issn-type":[{"value":"2296-858X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,10,5]]},"article-number":"1915489"}}